Choose the brand aligned with your industry so we can best serve your needs.
For researchers, scientists, and technical professionals: Your one-stop shop for the complete range of laboratory, production, and safety products and services.
Organocopper compounds have bonds between carbon and copper atoms and commonly have Cu(I) oxidation states. As organic chemistry reagents, they are used during organic synthesis as mild, selective nucleophiles for substitution and conjugate addition reactions.
Cu is present in 1 (cuprous) valence state in CuCl. CuCl is a semiconductor having a wide band gap. It is a promising candidate for use in silicon-based optoelectronics since its lattice resembles with silicon. It participates in various reactions with Grignard reagents.
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
DOTA-EB-TATE is a peptide drug conjugate (PDC) composed of an SST peptide derivative, DOTA-octreotate, conjugated to an Evans blue analog (EB). This compound is utilized for its ability to improve the pharmacokinetics of SSTR2 analogs and reduce PRRT toxicity.
Improves the pharmacokinetics of SSTR2 analogs
Reduces PRRT toxicity
Can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs)
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
This peptide drug conjugate (PDC) is composed of an SST peptide derivative, DOTA-octreotate, conjugated to an Evans blue analog (EB). It is designed to improve the pharmacokinetics of SSTR2 analogs and reduce PRRT toxicity, and can also be utilized for the synthesis and research of Radionuclide-Drug Conjugates (RDCs).
Composed of an SST peptide derivative, DOTA-octreotate, conjugated to an Evans blue analog (EB)
Improves pharmacokinetics of SSTR2 analogs
Reduces PRRT toxicity
Utilized for the synthesis and research of Radionuclide-Drug Conjugates (RDCs)
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
DOTA-EB-TATE is a peptide drug conjugate (PDC) consisting of an SST peptide derivative, DOTA-octreotate, conjugated to an Evans blue analog (EB). It is designed to enhance the pharmacokinetics of SSTR2 analogs and reduce PRRT toxicity.
Enhances pharmacokinetics of SSTR2 analogs
Reduces PRRT toxicity
Useful for synthesis and research of Radionuclide-Drug Conjugates (RDCs)
Functions as a peptide drug conjugate (PDC)
Applicable in cancer targeted therapy
Used in cancer metabolism and metastasis research
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More